HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Responsiveness of metastatic basal-cell carcinoma to chemotherapy. A case report.

Abstract
Basal cell carcinoma normally causes major morbidity only by direct extension of the tumor into adjacent tissues. Occasionally the tumor will metastasize to distant sites such as the lungs, the bones, regional lymph nodes, and the abdominal viscera. Over 100 cases of this disseminated disease are reported in the literature. Once a tumor has metastasized beyond the regional lymph nodes it is uniformly fatal. This article reports a case of basal cell carcinoma, metastatic to the lung, which was successfully treated with cisplatin. Three other cases treated similarly are reviewed, and the prospects for treatment of advanced basal cell carcinomas with chemotherapy are discussed.
AuthorsT J Wieman, E H Shively, T M Woodcock
JournalCancer (Cancer) Vol. 52 Issue 9 Pg. 1583-5 (Nov 01 1983) ISSN: 0008-543X [Print] United States
PMID6684499 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Cisplatin
Topics
  • Carcinoma, Basal Cell (diagnostic imaging, drug therapy, secondary)
  • Cisplatin (therapeutic use)
  • Humans
  • Lung Neoplasms (diagnostic imaging, drug therapy, secondary)
  • Male
  • Middle Aged
  • Radiography
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: